Other Species / Isoforms
  VAMP1 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S2-p
______MsAPAQPPA
0 1
VAMP1 (human) ______MsAPAQPPA S2-p
VAMP1 (mouse) ______MSAPAQPPA S2
VAMP1 iso2 (mouse) ______MSAPAQPPA S2
VAMP1 (rat) ______MSAPAQPPA S2
K54-ub
IIRVNVDkVLERDQk
Upstream
0 98
Treatment
  • MG132
VAMP1 (human) IIRVNVDkVLERDQk K54-ub
VAMP1 (mouse) IMRVNVDkVLERDQk K54-ub
VAMP1 iso2 (mouse) IMRVNVDKVLERDQK K54
VAMP1 (rat) IMRVNVDKVLERDQK K54
K61-ub
kVLERDQkLsELDDR
0 89
VAMP1 (human) kVLERDQkLsELDDR K61-ub
VAMP1 (mouse) kVLERDQkLsELDDR K61-ub
VAMP1 iso2 (mouse) KVLERDQKLSELDDR K61
VAMP1 (rat) KVLERDQKLsELDDR K61
S63-p
LERDQkLsELDDRAD
Upstream
0 22
Treatment
  • nocodazole
  • selumetinib
  • vemurafenib
VAMP1 (human) LERDQkLsELDDRAD S63-p
VAMP1 (mouse) LERDQkLsELDDRAD S63-p
VAMP1 iso2 (mouse) LERDQKLSELDDRAD S63
VAMP1 (rat) LERDQKLsELDDRAD S63-p
S77
DALQAGASQFESSAA
0 1
VAMP1 (human) DALQAGASQFESSAA S77
VAMP1 (mouse) DALQAGAsQFESsAA S77-p
VAMP1 iso2 (mouse) DALQAGASQFESSAA S77
VAMP1 (rat) DALQAGASVFESSAA S77
S82
GASQFESSAAkLKRK
0 1
VAMP1 (human) GASQFESSAAkLKRK S82
VAMP1 (mouse) GAsQFESsAAkLKRK S82-p
VAMP1 iso2 (mouse) GASQFESSAAKLKRK S82
VAMP1 (rat) GASVFESSAAKLKRK S82
K85-ub
QFESSAAkLKRKYWW
0 3
VAMP1 (human) QFESSAAkLKRKYWW K85-ub
VAMP1 (mouse) QFESsAAkLKRKYWW K85-ub
VAMP1 iso2 (mouse) QFESSAAKLKRKYWW K85
VAMP1 (rat) VFESSAAKLKRKYWW K85